查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1828110

2025年全球药物输注系统市场报告

Drug Infusion Systems Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，药物输液系统市场呈现强劲成长势头，市场规模从2024年的134.2亿美元增至2025年的142.3亿美元，复合年增长率达6.1%。这段时期的成长可归因于向电子输液设备的转变、慢性病盛行率的上升、患者照护的进步、居家输液治疗以及门诊照护环境的扩展。

预计未来几年药物输液系统市场将强劲成长，2029年将达到202.3亿美元，年复合成长率（CAGR）为9.2%。预测期内的成长动力包括：向一次性系统的转变、慢性病盛行率的上升、门诊护理设施的扩张、个人化医疗和自适应剂量以及居家照护需求的不断增长。预测期内的主要趋势包括无线连接和远端监控、电子健康记录（EHR）整合、智慧型帮浦技术、个人化医疗和自适应剂量以及微创输液技术。

药物输注系统属于医疗设备，它透过导管或针头将药物和液体输送到病人体内。这种输送方式通常用于医院、诊所和各种医疗机构，用于输送止痛药、抗生素、化疗药物和液体等药物给病人。

药物输注系统的主要类别包括弹性输注系统、一次性输注系统、注射器输注系统、蠕动帮浦、多通道帮浦、病人自控镇痛 (PCA) 帮浦、胰岛素帮浦和植入式输注系统。例如，弹性输注系统是一种灵活的容器，旨在以恆定速率输送药物，用于短期输注治疗。它们用于医院、诊所和家庭护理环境中的短期药物输注治疗。这些多功能係统可以透过各种方法给药，包括静脉、皮下、动脉内和颅外给药​​。它们服务于广泛的医疗应用，包括化疗、化疗、糖尿病、镇痛、营养、血液学和小儿科。各种最终用户，包括医院、门诊手术中心和诊断中心，都利用弹性输注系统来满足他们的特定需求。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响，尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要医疗设备重新认证，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供药物输液系统市场统计数据，例如全球市场规模、区域份额、竞争对手的市场份额、详细的药物输液系统细分市场、市场趋势和商机，以及在药物输液系统行业取得成功所需的数据。本药物输液系统市场研究报告提供您所需的全面展望，并详细分析了该行业的现状和未来趋势。

未来五年的预测成长率为9.2%，较我们先前对该市场的预测略有下降0.1%。这一下降主要源自于美国与其他国家之间关税的影响。这可能会透过对来自奥地利和英国等主要地区的蠕动泵装置和阻塞检测感测器征收关税直接影响美国，从而导致化疗输送挑战和肿瘤治疗成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响也将更加广泛地显现。

慢性病盛行率的上升预计将推动未来药物输注系统市场的扩张。癌症、糖尿病、心血管疾病和自体免疫疾病等慢性疾病通常需要长期或持续输注治疗。药物输注系统为这些疾病患者提供了一种安全、高效且有效的给药方式。中低收入国家的慢性病盛行率成长速度快于高所得国家。糖尿病是导致肾衰竭、心臟病发作、中风、失明和下肢截肢的主要原因。例如，根据美国疾病管制与预防中心 (CDC) 2024 年 2 月的一份报告，患有多种慢性病的美国数量正在增加，42% 的人报告患有两种或两种以上的疾病，12% 的人报告患有五种或五种以上的疾病。因此，慢性病盛行率的上升正在推动药物输注系统市场的成长。

预计不断增长的医疗支出将在未来几年推动药物输注系统市场的成长。医疗支出是指在特定期间（通常为一年）内分配给医疗保健商品和服务的总金额。随着医疗支出的增加，医院、诊所和其他医疗机构将有资源投资于先进的药物输注系统，增加对这些设备的需求。例如，2024 年 5 月，英国国家统计机构国家统计局 (ONS) 报告称，从 2022 年到 2023 年，医疗保健总支出名义上将增加 5.6%，但 2022 年的成长率仅为 0.9%。因此，预计不断增长的医疗支出将推动药物输注系统市场的成长。

药物输液系统市场的主要企业正专注于开发先进技术，例如云端基础的输液管理系统，旨在改善患者照护、提高准确性并简化输液治疗的管理。云端基础的输液管理系统是数位平台，可透过云端监控、管理和追踪药物输液。例如，2023 年 6 月，先进输液治疗和药物输送解决方案的全球领导者 Eitan Medical（美国）推出了 Eitan Insights，这是一款新的云端基础的输液管理系统，旨在满足家庭输液和专业输液的特殊需求。 Eitan Insights 为医疗保健专业人员提供即时数据和分析，使他们能够远端监控患者并根据需要调整治疗计划。该系统透过最大限度地降低错误风险和提高对制定的协议的遵守来提高用药安全性。

为了获得竞争优势，药物输注系统市场的主要参与企业正专注于开发创新产品，例如药物输送系统。药物输送系统包括各种创新工具和系统，旨在增强药物管理的安全、准确和高效。例如，2023年2月，中国医疗设备製造商迈瑞医疗国际有限公司推出了BeneFusion i/u系列输液系统。这些系统提供无与伦比的精确度、灵活的客製化和卓越的简单性，确保各种临床环境下的药物安全。 BolusGUARD电子注射器装载系统采用正在申请专利的自动离合器技术，可避免装载错误并确保输液过程每一步的准确性。其用户友好的介面和直觉的设计简化了工作流程并提升了用户体验。

2022年3月，总部位于德国的製药公司费森尤斯卡比（Fresenius Kabi）以2.4亿美元收购了Ivenix公司。此次策略性收购旨在扩大费森尤斯卡比的输液治疗产品组合，并巩固其在输液系统市场的地位。透过此次收购，费森尤斯卡比将提供全面、先进的优质输液治疗产品，造福病患、客户和相关人员。被收购的Ivenix是一家总部位于美国的医疗技术公司，专门从事输液系统的开发。

药物输液系统市场的主要企业包括美敦力公司、百特国际公司、ICU Medical Inc.、Becton Dickinson and Company、Smiths Group plc、Tandem Diabetes Care Inc.、Terumo Corporatio、Halyard Health Inc.、Insulet Corporation、Zyno Medical Inc.、Braun Melsungen AG、 KGaA、强生公司、Hospira、Alaris Health Systems Inc.、B. Braun Melsungen AG、Disetronic Medical Systems AG、Accu-Chek、Abbott Diabetes Care Inc.、Novo Nordisk A/S、Eli Lilly and Company、Sanofi-Aventis Care Inc.、Novo Nordisk A/S、Eli Lilly and Company、Sanofi-Aventis、Ypsomed Holding AG 和 Valeritas Inc.

2024年，北美是药物输液系统市场最大的地区。根据全球药物输液系统市场报告，预计亚太地区在预测期内将成为成长最快的地区。此药物输液系统市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。

药物输液系统市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙

药物输注系统市场涵盖智慧帮浦、注射式帮浦、肠内输注系统和局部输注系统的销售。该市场的价值指的是“出厂价”，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球药物输液系统：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球药物输注系统市场：成长率分析
  • 全球药物输注系统市场表现：规模与成长，2019-2024
  • 全球药物输注系统市场预测：规模与成长，2024-2029年，2034年
  • 全球药物输注系统：总潜在市场（TAM）

第六章 市场细分

  • 全球药物输注系统市场（按产品类型、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 弹性体注射系统
  • 一次性输液系统
  • 注射器注射系统
  • 蠕动帮浦
  • 多通道泵浦
  • 病人自控镇痛（PCA）泵
  • 胰岛素帮浦
  • 植入式输液系统
  • 全球药物输注系统市场（依给药途径）：2019-2024 年、2024-2029 年、2034 年绩效及预测
  • 静脉
  • 皮下
  • 动脉
  • 硬脊膜外麻醉
  • 其他的
  • 全球药物输注系统市场的应用、绩效与预测（2019-2024 年、2024-2029 年、2034 年）
  • 肿瘤学和化疗
  • 糖尿病
  • 止痛药
  • 营养
  • 血液学
  • 孩子们
  • 其他的
  • 全球药物输注系统市场（依最终使用者、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 门诊手术中心
  • 诊断中心
  • 其他的
  • 全球药物输液系统市场：弹性输液系统细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 无排气弹性体泵
  • 排气弹性体泵
  • 全球药物输液系统市场：一次性输液系统细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 一次性输液泵
  • 一次性部件输液器
  • 全球药物注射系统市场：注射器注射系统细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 手动注射输液帮浦
  • 电动注射输液帮浦
  • 全球药物输注系统市场：蠕动帮浦细分市场、类型、性能及预测（2019-2024、2024-2029、2034）
  • 单通道蠕动泵
  • 多通道蠕动泵
  • 全球药物输注系统市场：多通道帮浦细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 通用多通道输液泵
  • 用于特定治疗的多通道泵
  • 全球药物输注系统市场：病患自控镇痛 (PCA) 帮浦细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 电子PCA泵
  • 机械PCA泵
  • 全球药物输注系统市场：胰岛素帮浦细分、类型、效能及预测（2019-2024、2024-2029、2034）
  • 持续皮下胰岛素输注（CSII）泵
  • 贴片式胰岛素帮浦
  • 全球药物输注系统市场：植入式输注系统细分，按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 用于治疗慢性疼痛的植入式泵
  • 植入式化疗泵

第七章 区域和国家分析

  • 全球药物输注系统市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球药物输注系统市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 药物输注系统市场：竞争格局
  • 药物输注系统市场：公司简介
    • Medtronic plc
    • Baxter International Inc.
    • ICU Medical Inc.
    • Becton Dickinson and Company
    • Smiths Group plc

第31章：其他领先和创新企业

  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Halyard Health Inc.
  • Insulet Corporation
  • Zyno Medical Inc.
  • Braun Melsungen AG
  • Flowonix Medical Inc.
  • IRadimed Corporation
  • Moog Inc.
  • DebIoTech SA
  • Fresenius SE & Co. KGaA
  • Johnson & Johnson
  • Hospira
  • Alaris Health Systems Inc.
  • B. Braun Melsungen AG

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年药物输注系统市场：提供新机会的国家
  • 2029年药物输注系统市场：细分市场带来新机会
  • 2029年药物输注系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r24097u

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from $13.42 billion in 2024 to $14.23 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to shift to electronic infusion devices, increased prevalence of chronic diseases, patient care advancements, home-based infusion therapy, expansion of ambulatory care settings.

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $20.23 billion in 2029 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care. Major trends in the forecast period include wireless connectivity and remote monitoring, integration with electronic health records (ehr), smart pump technology, personalized and adaptive dosing, minimally invasive infusion techniques.

The forecast of 9.2% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on peristaltic pump mechanisms and occlusion detection sensors, sourced from key regions such as Austria and the UK, which could lead to chemotherapy delivery challenges and increased oncology treatment costs.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the drug infusion system market in the future. Chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders frequently necessitate long-term or continuous infusion therapy. Drug infusion systems provide a safe, efficient, and effective means of delivering medication to patients with these conditions. The prevalence of chronic diseases is rising more rapidly in low- and middle-income countries compared to high-income nations. Diabetes, in particular, is a significant contributor to renal failure, heart attacks, strokes, blindness, and lower limb amputations. For example, in February 2024, reports from the Centers for Disease Control and Prevention (CDC), a U.S.-based organization, indicated that an increasing number of Americans are dealing with multiple chronic conditions, with 42% reporting two or more conditions and 12% experiencing five or more. Therefore, the rising prevalence of chronic diseases is driving the growth of the drug infusion system market.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

Major players in the drug infusion systems market are directing their efforts towards developing innovative products, such as medication delivery systems, to gain a competitive advantage. Medication delivery systems encompass a diverse range of innovative tools and systems designed to enhance the safe, accurate, and efficient administration of medications. For instance, in February 2023, Mindray Medical International Limited, a China-based manufacturer of medical instrumentation, launched the BeneFusion i/u Series Infusion Systems. These systems provide unparalleled accuracy, adaptive customization, and remarkable simplicity, ensuring guaranteed medication safety in various clinical settings. The BolusGUARD motorized syringe loading system with patent-pending automatic clutch technology prevents loading errors, securing every step of the infusion process. The user-friendly interface and intuitive design streamline workflows and enhance the user experience.

In March 2022, Fresenius Kabi, a pharmaceutical company based in Germany, acquired Ivenix Inc. for $240 million. This strategic acquisition aims to expand Fresenius Kabi's portfolio of infusion therapy products and strengthen its position in the infusion system market. The acquisition positions Fresenius Kabi to offer a comprehensive and leading set of premium infusion therapy products for the benefit of patients, customers, and stakeholders. Ivenix, the acquired company, is a medical technology company based in the United States, specializing in the development of infusion systems.

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

North America was the largest region in the drug infusion systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
  • 2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
  • 3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
  • 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
  • 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
  • 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
  • 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
  • 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; ICU Medical Inc.; Becton Dickinson and Company; Smiths Group plc; Tandem Diabetes Care Inc.; Terumo Corporation; Halyard Health Inc.; Insulet Corporation; Zyno Medical Inc.; Braun Melsungen AG; Flowonix Medical Inc.; IRadimed Corporation; Moog Inc.; Debiotech S.A.; Fresenius SE & Co. KGaA; Johnson & Johnson; Hospira; Alaris Health Systems Inc.; B. Braun Melsungen AG; Disetronic Medical Systems AG; Accu-Chek; Abbott Diabetes Care Inc.; Novo Nordisk A/S; Eli Lilly and Company; Sanofi-Aventis; Ypsomed Holding AG; Valeritas Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Infusion Systems Market Characteristics

3. Drug Infusion Systems Market Trends And Strategies

4. Drug Infusion Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drug Infusion Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Infusion Systems Market Growth Rate Analysis
  • 5.4. Global Drug Infusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Infusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Infusion Systems Total Addressable Market (TAM)

6. Drug Infusion Systems Market Segmentation

  • 6.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastomeric Infusion System
  • Disposable Infusion System
  • Syringe Infusion System
  • Peristaltic Pump
  • Multi-Channel Pump
  • Patient-Controlled Analgesia (PCA) Pump
  • Insulin Pump
  • Implantable Infusion System
  • 6.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous
  • Subcutaneous
  • Arterial
  • Epidural
  • Other Routes Of Administration
  • 6.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology And Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Hematology
  • Pediatrics
  • Other Applications
  • 6.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Vented Elastomeric Pumps
  • Vented Elastomeric Pumps
  • 6.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Infusion Pumps
  • IV Sets With Disposable Components
  • 6.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Syringe Infusion Pumps
  • Electric Syringe Infusion Pumps
  • 6.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Channel Peristaltic Pumps
  • Multi-Channel Peristaltic Pumps
  • 6.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Channel Infusion Pumps For General Use
  • Multi-Channel Pumps For Specific Therapies
  • 6.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic PCA Pumps
  • Mechanical PCA Pumps
  • 6.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Subcutaneous Insulin Infusion (CSII) Pumps
  • Patch Insulin Pumps
  • 6.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Pumps For Chronic Pain
  • Implantable Pumps For Chemotherapy

7. Drug Infusion Systems Market Regional And Country Analysis

  • 7.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Infusion Systems Market

  • 8.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Infusion Systems Market

  • 9.1. China Drug Infusion Systems Market Overview
  • 9.2. China Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Infusion Systems Market

  • 10.1. India Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Infusion Systems Market

  • 11.1. Japan Drug Infusion Systems Market Overview
  • 11.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Infusion Systems Market

  • 12.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Infusion Systems Market

  • 13.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Infusion Systems Market

  • 14.1. South Korea Drug Infusion Systems Market Overview
  • 14.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Infusion Systems Market

  • 15.1. Western Europe Drug Infusion Systems Market Overview
  • 15.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Infusion Systems Market

  • 16.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Infusion Systems Market

  • 17.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Infusion Systems Market

  • 18.1. France Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Infusion Systems Market

  • 19.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Infusion Systems Market

  • 20.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Infusion Systems Market

  • 21.1. Eastern Europe Drug Infusion Systems Market Overview
  • 21.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Infusion Systems Market

  • 22.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Infusion Systems Market

  • 23.1. North America Drug Infusion Systems Market Overview
  • 23.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Infusion Systems Market

  • 24.1. USA Drug Infusion Systems Market Overview
  • 24.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Infusion Systems Market

  • 25.1. Canada Drug Infusion Systems Market Overview
  • 25.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Infusion Systems Market

  • 26.1. South America Drug Infusion Systems Market Overview
  • 26.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Infusion Systems Market

  • 27.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Infusion Systems Market

  • 28.1. Middle East Drug Infusion Systems Market Overview
  • 28.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Infusion Systems Market

  • 29.1. Africa Drug Infusion Systems Market Overview
  • 29.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 30.1. Drug Infusion Systems Market Competitive Landscape
  • 30.2. Drug Infusion Systems Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. ICU Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug Infusion Systems Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Terumo Corporation
  • 31.3. Halyard Health Inc.
  • 31.4. Insulet Corporation
  • 31.5. Zyno Medical Inc.
  • 31.6. Braun Melsungen AG
  • 31.7. Flowonix Medical Inc.
  • 31.8. IRadimed Corporation
  • 31.9. Moog Inc.
  • 31.10. Debiotech S.A.
  • 31.11. Fresenius SE & Co. KGaA
  • 31.12. Johnson & Johnson
  • 31.13. Hospira
  • 31.14. Alaris Health Systems Inc.
  • 31.15. B. Braun Melsungen AG

32. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Infusion Systems Market

34. Recent Developments In The Drug Infusion Systems Market

35. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Infusion Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Infusion Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Infusion Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer